+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lumbar Degenerative Disc Disease Market by Treatment Type (Non Surgical, Surgical), Product (Bone Graft Material, Orthobiologics, Spinal Implants), End User, Insurance Coverage, Age Group - Global Forecast 2025-2030- Product Image
Lumbar Degenerative Disc Disease Market by Treatment Type (Non Surgical, Surgical), Product (Bone Graft Material, Orthobiologics, Spinal Implants), End User, Insurance Coverage, Age Group - Global Forecast 2025-2030- Product Image
Sale

Lumbar Degenerative Disc Disease Market by Treatment Type (Non Surgical, Surgical), Product (Bone Graft Material, Orthobiologics, Spinal Implants), End User, Insurance Coverage, Age Group - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5944537
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Lumbar Degenerative Disc Disease Market is experiencing sustained momentum, driven by innovations in therapies, evolving regulatory landscapes, and increasing demand for advanced treatment modalities. Senior decision-makers require an in-depth understanding to navigate shifting care models, clinical preferences, and global supply chain factors in this dynamic sector.

Market Snapshot: Lumbar Degenerative Disc Disease Market

The global market for lumbar degenerative disc disease treatment expanded from USD 796.33 million in 2024 to USD 855.87 million in 2025 and is projected to maintain a 7.20% CAGR through 2030, ultimately reaching USD 1.20 billion. Growth is fueled by the adoption of minimally invasive techniques, broader access to innovative biologics, and the digitization of care pathways. Industry stakeholders in medical devices, therapeutics, payers, and provider networks are actively responding to expanding patient needs and emerging clinical practice guidelines.

Scope & Segmentation

  • Treatment Types: Non-surgical care features interventional therapies (epidural steroid injections, facet joint injections, nerve blocks, radiofrequency ablation), pharmaceuticals (corticosteroids, muscle relaxants, NSAIDs, opioids), and physical therapy approaches (exercise, manual, traction). Surgical options include disc replacement, minimally invasive surgeries (endoscopic, microscopic, percutaneous), and spinal fusion (anterior, interbody, lateral, posterolateral, transforaminal).
  • Product Categories: Bone graft materials (allograft, autograft, synthetic), orthobiologics (growth factors, platelet-rich plasma, stem cell therapies), spinal implants (disc replacement devices, interbody fusion cages, pedicle screw systems), and surgical instruments make up the diverse product landscape.
  • End Users: Care delivery spans ambulatory surgery centers, clinics, general hospitals, and specialty hospitals, illustrating broad adoption of advanced technologies across healthcare settings.
  • Insurance Coverage: Private insurance, public insurance, and uninsured/self-pay patients influence market access and therapy uptake.
  • Age Groups: Distinct clinical approaches and product demands are seen across age brackets: 18–44, 45–64, and 65 plus.
  • Regional Markets: The Americas lead adoption driven by R&D and robust hospital infrastructure, while Europe, Middle East, and Africa benefit from standardized protocols and public funding. Asia-Pacific sees accelerated investment in healthcare and manufacturing, supported by government initiatives and aging demographics.
  • Key Industry Players: Leading companies include Medtronic plc, DePuy Synthes, Inc., Stryker Corporation, Zimmer Biomet Holdings, Inc., NuVasive, Inc., Globus Medical, Inc., Orthofix Medical Inc., SeaSpine Holdings Corporation, RTI Surgical Holdings, Inc., and Alphatec Holdings, Inc.

Key Takeaways for Senior Decision-Makers

  • Minimally invasive surgical platforms, biologics, and digital health tools are transforming treatment pathways and broadening patient eligibility for advanced care solutions.
  • Therapy options and technology adoption vary based on patient demographics, payer considerations, and clinical infrastructure, requiring tailored commercial and clinical strategies.
  • Collaboration between device manufacturers and clinical procurement teams is essential to balance innovation, cost management, and consistent patient outcomes.
  • Data-driven care models, including remote monitoring and tele-rehabilitation, are enabling proactive patient management and resource optimization across provider networks.
  • Partnerships among technology developers, regulators, and academic institutions are expediting validation and commercialization of next-generation therapies.
  • Regional supply chain and policy dynamics, including incentives for domestic manufacturing, are altering sourcing strategies and procedural economics.

Impact of US Tariff Policy

Recent US trade tariffs on imported spinal implants and biologic materials have heightened procurement costs and induced a shift toward domestic production and diversified sourcing. Hospitals and device manufacturers are adapting through renegotiated vendor agreements, regional production hubs, and collaboration on cost-effective solutions, fostering a resilient supply ecosystem.

Methodology & Data Sources

This report integrates a structured combination of secondary research—spanning clinical studies, government health databases, and industry analysis—with direct input from clinicians, procurement leaders, and payers via interviews and surveys. Cross-functional expert reviews ensured the accuracy and robustness of the market insights delivered.

Why This Report Matters

  • Enables forecasting and proactive alignment of product, investment, and sourcing strategies with shifting care trends across diverse global markets.
  • Equips decision-makers with actionable intelligence to optimize care models, engage stakeholder partnerships, and navigate regional policy changes.
  • Supports identification of commercial opportunities in emerging therapy modalities, patient demographics, and technology-driven care solutions.

Conclusion

Senior leaders seeking to guide strategic growth in lumbar degenerative disc disease will find this report essential for navigating evolving clinical, operational, and market dynamics. Invest in evidence-based innovation and multi-stakeholder engagement to maintain leadership in a fast-changing healthcare environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growing adoption of minimally invasive endoscopic discectomy procedures for lumbar disc degeneration
5.2. Rising demand for biologic therapies including platelet-rich plasma and stem cell injections for lumbar DDD
5.3. Increasing investment in dynamic stabilization devices to preserve segmental motion in lumbar DDD
5.4. Expansion of 3D printed interbody fusion cages customized to patient anatomy for enhanced lumbar fusion outcomes
5.5. Emergence of artificial intervertebral disc replacement technologies with improved biomaterials for lumbar DDD
5.6. Strategic collaborations between medtech companies and academic centers for innovative lumbar DDD solutions
5.7. Advanced imaging techniques leveraging AI algorithms for precise diagnosis of lumbar degenerative disc pathology
5.8. Growing preference for outpatient surgical centers to perform lumbar DDD procedures under local anesthesia
5.9. Implementation of telehealth platforms for preoperative assessment and postoperative monitoring in lumbar DDD patients
5.10. Focus on cost-effective, value-based care models driving reimbursement policies for lumbar degenerative disc therapies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Lumbar Degenerative Disc Disease Market, by Treatment Type
8.1. Introduction
8.2. Non Surgical
8.2.1. Interventional Therapy
8.2.1.1. Epidural Steroid Injection
8.2.1.2. Facet Joint Injection
8.2.1.3. Nerve Block
8.2.1.4. Radiofrequency Ablation
8.2.2. Pharmaceutical
8.2.2.1. Corticosteroids
8.2.2.2. Muscle Relaxants
8.2.2.3. Nsaids
8.2.2.4. Opioids
8.2.3. Physical Therapy
8.2.3.1. Exercise Therapy
8.2.3.2. Manual Therapy
8.2.3.3. Traction Therapy
8.3. Surgical
8.3.1. Disc Replacement
8.3.2. Minimally Invasive Therapy
8.3.2.1. Endoscopic Surgery
8.3.2.2. Microscopic Surgery
8.3.2.3. Percutaneous Procedures
8.3.3. Spinal Fusion
8.3.3.1. Anterior Fusion
8.3.3.2. Interbody Fusion
8.3.3.3. Lateral Fusion
8.3.3.4. Posterolateral Fusion
8.3.3.5. Transforaminal Fusion
9. Lumbar Degenerative Disc Disease Market, by Product
9.1. Introduction
9.2. Bone Graft Material
9.2.1. Allograft
9.2.2. Autograft
9.2.3. Synthetic
9.3. Orthobiologics
9.3.1. Growth Factors
9.3.2. Platelet Rich Plasma
9.3.3. Stem Cell Therapies
9.4. Spinal Implants
9.4.1. Disc Replacement Devices
9.4.2. Interbody Fusion Cages
9.4.3. Pedicle Screw Systems
9.5. Surgical Instruments
10. Lumbar Degenerative Disc Disease Market, by End User
10.1. Introduction
10.2. Ambulatory Surgery Center
10.3. Clinic
10.4. Hospital
10.4.1. General Hospital
10.4.2. Specialty Hospital
11. Lumbar Degenerative Disc Disease Market, by Insurance Coverage
11.1. Introduction
11.2. Private Insurance
11.3. Public Insurance
11.4. Uninsured
12. Lumbar Degenerative Disc Disease Market, by Age Group
12.1. Introduction
12.2. 18-44
12.3. 45-64
12.4. 65 Plus
13. Americas Lumbar Degenerative Disc Disease Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Lumbar Degenerative Disc Disease Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Lumbar Degenerative Disc Disease Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Medtronic plc
16.3.2. DePuy Synthes, Inc.
16.3.3. Stryker Corporation
16.3.4. Zimmer Biomet Holdings, Inc.
16.3.5. NuVasive, Inc.
16.3.6. Globus Medical, Inc.
16.3.7. Orthofix Medical Inc.
16.3.8. SeaSpine Holdings Corporation
16.3.9. RTI Surgical Holdings, Inc.
16.3.10. Alphatec Holdings, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. LUMBAR DEGENERATIVE DISC DISEASE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. LUMBAR DEGENERATIVE DISC DISEASE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. LUMBAR DEGENERATIVE DISC DISEASE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. LUMBAR DEGENERATIVE DISC DISEASE MARKET: RESEARCHAI
FIGURE 26. LUMBAR DEGENERATIVE DISC DISEASE MARKET: RESEARCHSTATISTICS
FIGURE 27. LUMBAR DEGENERATIVE DISC DISEASE MARKET: RESEARCHCONTACTS
FIGURE 28. LUMBAR DEGENERATIVE DISC DISEASE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. LUMBAR DEGENERATIVE DISC DISEASE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY EPIDURAL STEROID INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY EPIDURAL STEROID INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY FACET JOINT INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY FACET JOINT INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NERVE BLOCK, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NERVE BLOCK, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MUSCLE RELAXANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MUSCLE RELAXANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NSAIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NSAIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY OPIOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY EXERCISE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY EXERCISE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MANUAL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MANUAL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TRACTION THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TRACTION THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY DISC REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY DISC REPLACEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ENDOSCOPIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ENDOSCOPIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MICROSCOPIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MICROSCOPIC SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PERCUTANEOUS PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PERCUTANEOUS PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ANTERIOR FUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ANTERIOR FUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERBODY FUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERBODY FUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY LATERAL FUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY LATERAL FUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY POSTEROLATERAL FUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY POSTEROLATERAL FUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TRANSFORAMINAL FUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TRANSFORAMINAL FUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ALLOGRAFT, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ALLOGRAFT, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AUTOGRAFT, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AUTOGRAFT, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SYNTHETIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PLATELET RICH PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PLATELET RICH PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY DISC REPLACEMENT DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY DISC REPLACEMENT DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERBODY FUSION CAGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERBODY FUSION CAGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PEDICLE SCREW SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PEDICLE SCREW SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY GENERAL HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY GENERAL HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPECIALTY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPECIALTY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRIVATE INSURANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRIVATE INSURANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PUBLIC INSURANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PUBLIC INSURANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY UNINSURED, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY UNINSURED, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY 18-44, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY 18-44, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY 45-64, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY 45-64, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY 65 PLUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY 65 PLUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 211. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 212. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 213. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2024 (USD MILLION)
TABLE 214. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2025-2030 (USD MILLION)
TABLE 215. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 216. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 217. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 218. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 219. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 220. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 221. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 222. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 223. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2024 (USD MILLION)
TABLE 224. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2025-2030 (USD MILLION)
TABLE 225. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 226. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 227. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 228. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 229. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2024 (USD MILLION)
TABLE 230. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2025-2030 (USD MILLION)
TABLE 231. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2024 (USD MILLION)
TABLE 232. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2025-2030 (USD MILLION)
TABLE 233. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2018-2024 (USD MILLION)
TABLE 234. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2025-2030 (USD MILLION)
TABLE 235. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 238. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 239. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2018-2024 (USD MILLION)
TABLE 240. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2025-2030 (USD MILLION)
TABLE 241. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 242. CANADA LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 243. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 244. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 245. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2024 (USD MILLION)
TABLE 246. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2025-2030 (USD MILLION)
TABLE 247. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 248. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 249. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 250. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 251. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 252. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 253. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 254. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 255. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2024 (USD MILLION)
TABLE 256. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2025-2030 (USD MILLION)
TABLE 257. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 258. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 259. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 260. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 261. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2024 (USD MILLION)
TABLE 262. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2025-2030 (USD MILLION)
TABLE 263. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2018-2024 (USD MILLION)
TABLE 264. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY ORTHOBIOLOGICS, 2025-2030 (USD MILLION)
TABLE 265. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2018-2024 (USD MILLION)
TABLE 266. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL IMPLANTS, 2025-2030 (USD MILLION)
TABLE 267. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 270. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 271. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2018-2024 (USD MILLION)
TABLE 272. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INSURANCE COVERAGE, 2025-2030 (USD MILLION)
TABLE 273. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 274. MEXICO LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY NON SURGICAL, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY INTERVENTIONAL THERAPY, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHARMACEUTICAL, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PHYSICAL THERAPY, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SURGICAL, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY MINIMALLY INVASIVE THERAPY, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY SPINAL FUSION, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL LUMBAR DEGENERATIVE DISC DISEASE MARKET SIZE, BY BONE GRAFT MATERIAL, 2025-2030 (USD MILLION)
T

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Lumbar Degenerative Disc Disease market report include:
  • Medtronic plc
  • DePuy Synthes, Inc.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • NuVasive, Inc.
  • Globus Medical, Inc.
  • Orthofix Medical Inc.
  • SeaSpine Holdings Corporation
  • RTI Surgical Holdings, Inc.
  • Alphatec Holdings, Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 855.87 Million
Forecasted Market Value ( USD ) by 2030 $ 1200 Million
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Lumbar Degenerative Disc Disease Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

Lumbar Degenerative Disc Disease Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 184 Pages
  • Global
From
Degenerative Disc Disease Drug Pipeline Analysis Report 2025 - Product Image

Degenerative Disc Disease Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From
Degenerative Disc Disease Treatment Market Report 2025 - Product Image

Degenerative Disc Disease Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Degenerative Disc Disease Market by Product Category (Devices, Services, Therapeutics), Treatment Type (Non-Surgical Treatment, Surgical Treatment), Device Type, Drug Class, End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Degenerative Disc Disease Market by Product Category (Devices, Services, Therapeutics), Treatment Type (Non-Surgical Treatment, Surgical Treatment), Device Type, Drug Class, End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Degenerative Disc Disease Treatment - Global Strategic Business Report - Product Image

Degenerative Disc Disease Treatment - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.